Screener
Veracyte VCYT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.001 par value; 125,000,000 shares authorized, 79,791,856 and 79,359,005 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 80 | 79 |
| Additional paid-in capital | 1,701,470 | 1,695,339 |
| Accumulated deficit | (348,923) | (377,630) |
| Accumulated other comprehensive loss | (8,221) | (8,212) |
| Total stockholders’ equity | 1,344,406 | 1,309,576 |
| Total liabilities and stockholders’ equity | $1,436,400 | $1,406,019 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's retained earnings?
- Veracyte (VCYT) reported retained earnings of -$348.92M in Q1 2026.
- How has Veracyte's retained earnings changed year-over-year?
- Veracyte's retained earnings increased by 20.1% year-over-year, from -$436.94M to -$348.92M.
- What is the long-term trend for Veracyte's retained earnings?
- Over 5 years (2020 to 2025), Veracyte's retained earnings has grown at a 6.0% compound annual growth rate (CAGR), from -$281.59M to -$377.63M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about Veracyte's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude